College: King's
Supervisor: Jacob Stegenga
Advisor: Stephen John
Thesis topic
My thesis focuses on the philosophy of cancer medicine, specifically precision oncology, an approach which seeks to 'personalize' cancer treatment using biomarkers and targeted drugs. I study a range of epistemic and ethical challenges raised by precision oncology, as well as broader issues in the ethics of communication in cancer medicine.
Research interests
Philosophy of medicine, values in science, science communication, bioethics, AI ethics
Prior education
2017 – Doctor of Medicine, University of Toronto
2015 – Master of Arts, History and Philosophy of Science, University of Toronto
2013 – Bachelor of Science, McGill University
Selected publications in philosophy
'Generalizations in clinical trials – do generics help or harm?' Kennedy Institute of Ethics Journal (forthcoming).
'Cancer Medicine and Precision Oncology' in Handbook of the Philosophy of Medicine, eds. Walker M, Schramme T. Springer (forthcoming).
'Concepts of actionability in precision oncology.' Philosophy of Science 2023; Sep 8:1–12 (with Anya Plutynski).
'Malignant by Vinay Prasad: Oncology's leading gadfly.' Philosophy of Medicine 2021; 2(1):1–7.
Selected talks in philosophy
'Making room for trust: Against "explainable AI"' (with Henrik Røed Sherling)
Philosophy of Medicine Roundtable (Virtual), May 2024.
Philosophy of Cancer Biology Workshop, University of Bordeaux, March 2024.
Objectivity, Trust and Values in Science Workshop, University of Cambridge, November 2023.
'Clinical communication: A model for scientific assertion?' (with Henrik Røed Sherling)
Stockholm Graduate Conference in Analytic Philosophy, University of Stockholm, December 2023.
Bergen Philosophy of Science Workshop, University of Bergen, October 2023.
'Minimal residual disease: Premises before promises'
International Society for the History, Philosophy and Social Studies of Biology Biennial Meeting, University of Toronto, Toronto, Canada, July 2023.
Philosophy in Biology and Medicine, University of Cambridge, May 2023.
'Driver genes, actionable mutations, and the scope and limits of AI in cancer medicine' (with Anya Plutynski)
Philosophy of Science Biennial Meeting, Pittsburgh, November 2022.